Key result
In vitro peniocerol normalizes meniscal inflammatory markers and strongly inhibits collagen and MMP13 expression.
Why the study?
Meniscal damage has a bidirectional relationship with osteoarthritis onset and progression, necessitating new therapeutic strategies that address both conditions.
Does peniocerol reduce inflammation and extracellular matrix degradation in human meniscal fibrochondrocytes exposed to IL-1β and TNF-α?
Population
Cultured human meniscal fibrochondrocyte cells
Comparison
Stimulation with TNF-alpha or IL-1beta with vs without peniocerol (300 and 500 uM)
Design
In vitro study
Authors
Loading...
Peniocerol normalizes markers in vitro; hypothesis-generating for degenerative polyarthritis and unsupported by low-certainty evidence.
Does peniocerol reduce inflammation and extracellular matrix degradation in human meniscal fibrochondrocytes exposed to IL-1β and TNF-α?
p-value: p=<0.001
Peniocerol demonstrates protective and restorative effects against pro-inflammatory cytokine-induced extracellular matrix degradation in human meniscal fibrochondrocytes in vitro.
Galicia-Canales et al. (2026) studied Osteoarthritis (in vitro inflammation model). Peniocerol vs. Untreated control, IL-1β alone, and TNF-α alone was evaluated on Expression of ACAN, type I+III collagen, type II collagen, MMP13, and p65 (p=<0.001). In an in vitro model of meniscal inflammation, peniocerol at 500 μM normalized ACAN, Col2A1, and p65 levels to control values and significantly inhibited COL I+III and MMP13 expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: